Agence France-Presse Hails Cereplast as “Greener Alternative to Plastic”

Agence France-Presse (AFP) praised Cereplast as a “greener alternative to plastic” in a recently published print article and video segment produced by the leading international news agency. Cereplast is a leading manufacturer of sustainable plastics that is manufactured under a proprietary bio-based process.

According to the article, Scheer is of the view that petroleum-based plastics will become outdated in the future giving way for other alternatives. When the price of sustainable plastics touches $95 dollars a barrel, the demand for it will increase significantly since it will be cheaper than the traditional plastic. Scheer states that algae can be used as a renewable resource as algae-based resins will enable company’s dealing with the supply of plastic to become environmentally sustainable and the industry’s dependence on oil will also be reduced.

A recent study from the University of Utrecht predicted an increase in the global demand for biodegradable plastic resins or those obtained from plant-based sources and bioplastics. This study predicted an increase by 400% to 890,000 metric tons by the year 2013. A recent article by CNN International predicted the US market to reach $10 billion on an annual basis by the year 2020.

Cereplast plans to market its first algae-based products in the year 2010. Scheer is of the opinion that algae can be used as a raw material for biopolymer feed stock and it can also be considered as an important renewable resource. Algae has the capacity to become a vital “green” feed stock for bioplastics and biofuels.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.